ICAM1 and neoplasm: Depending on the context, ICAM-1 can either benefit a cancer—for example, by facilitating the clustering of circulating tumor cells or acting in pro-tumorigenic signaling pathways—or it can benefit host survival by facilitating the recognition and destruction of tumor cells by the immune system.